MINERALYS THERAPEUTICS INC (MLYS) competitors & alternatives
Health Care · NASDAQ
MINERALYS THERAPEUTICS INC (MLYS)'s top competitors and alternatives — its most similar public companies — include AKEBIA THERAPEUTICS INC (AKBA), LEXICON PHARMACEUTICALS INC (LXRX), INOGEN INC (INGN), PROKIDNEY CORP CLASS A (PROK), VIEMED HEALTHCARE INC (VMD), ARDELYX INC (ARDX), Inspire Medical Systems (INSP), OMADA HEALTH INC (OMDA), ResMed (RMD), ADAPTHEALTH CORP (AHCO), DaVita (DVA) and LIQUIDIA CORP (LQDA). These are MINERALYS THERAPEUTICS INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top MLYS competitors & alternatives
-
AKEBIA THERAPEUTICS INCAKBAHealth Care
A biopharmaceutical company specialized in kidney disease therapeutics with a commercial portfolio for anemia and mineral metabolism and a pipeline of rare…
$1.26 (as of 2026-07-22) · market cap $349M
-
LEXICON PHARMACEUTICALS INCLXRXHealth Care
An early-stage commercial biopharmaceutical company with a gene-discovery platform advancing cardiovascular and metabolic therapies, headlined by…
$2.25 (as of 2026-07-22) · market cap $1.0B
-
INOGEN INCINGNHealth Care
Inogen is a medical technology company developing portable oxygen concentrators and respiratory devices to improve mobility and quality of life for patients…
$6.51 (as of 2026-07-22) · market cap $174M
-
PROKIDNEY CORP CLASS APROKHealth Care
ProKidney is pioneering a first-in-class autologous kidney cell therapy to slow kidney function decline in advanced CKD and diabetes patients, currently in…
$1.53 (as of 2026-07-22) · market cap $462M
-
VIEMED HEALTHCARE INCVMDHealth Care
Viemed provides home-based respiratory, chronic care, and women's health services with clinical practitioners delivering therapy and equipment rental to…
$11.92 (as of 2026-07-22) · market cap $456M
-
ARDELYX INCARDXHealth Care
Ardelyx commercializes tenapanor-based therapies (IBSRELA for IBS-C, XPHOZAH for kidney disease hyperphosphatemia) with a pipeline of next-generation NHE3…
$5.08 (as of 2026-07-22) · market cap $1.3B
-
Inspire Medical SystemsINSPHealth Care
Inspire Medical Systems manufactures implantable nerve stimulation devices that treat obstructive sleep apnea without surgery or continuous positive airway…
$50.40 (as of 2026-07-22) · market cap $1.5B
-
OMADA HEALTH INCOMDAHealth Care
Virtual care platform combining human health coaches and AI-driven technology to deliver preventive and chronic disease management programs for cardiometabolic…
$21.84 (as of 2026-07-22) · market cap $1.3B
-
ResMedRMDHealth Care
ResMed develops cloud-connected software platforms and digital devices for out-of-hospital care, spanning sleep apnea management, COPD treatment, and…
$192.91 (as of 2026-07-22) · market cap $28.2B
-
ADAPTHEALTH CORPAHCOHealth Care
AdaptHealth delivers home medical equipment, supplies, and chronic disease management services directly to patients, focusing on sleep apnea, respiratory…
$10.88 (as of 2026-07-22) · market cap $1.5B
-
DaVitaDVAHealth Care
Leading US dialysis and integrated kidney care provider serving end-stage renal disease patients across clinical centers, home-based settings, and transplant…
$232.08 (as of 2026-07-22) · market cap $15.0B
-
LIQUIDIA CORPLQDAHealth Care
Liquidia is a rare-disease biopharmaceutical company commercializing YUTREPIA, a next-generation inhaled treprostinil with proprietary particle engineering,…
$87.04 (as of 2026-07-22) · market cap $7.7B
Not quite? Describe exactly what you want →
Peers are MINERALYS THERAPEUTICS INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: MINERALYS THERAPEUTICS INC (MLYS).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.